Genetic Variation in <i>Neisseria meningitidis</i> Does Not Influence Disease Severity in Meningococcal Meningitis. [PDF]
Front Med (Lausanne), 2020 Neisseria meningitidis causes sepsis and meningitis in humans. It has been suggested that pathogen genetic variation determines variance in disease severity. Here we report results of a genome-wide association study of 486 N.
Kremer PHC +6 more
europepmc +4 more sources
Cerebral Venous Sinus Thrombosis in a Patient with Meningococcal Meningitis. [PDF]
Oman Med J, 2018 Meningococcal meningitis has a wide range of neurological complications. However, cerebral venous sinus thrombosis (CVST) following infection with Neisseria meningitidis is uncommon.
Chirakkara SKP +3 more
europepmc +4 more sources
Meningococcal meningitis and COVID-19 co-infection. [PDF]
BMJ Case Rep, 2020 Bacterial co-infection in the ongoing pandemic of COVID-19 is associated with poor outcomes but remains little understood. A 22-year-old woman presented with a 3-week history of fever, headache, neck stiffness, rigours and confusion.
Gallacher SD, Seaton A.
europepmc +2 more sources
Characterization of strains of Neisseria meningitidis causing meningococcal meningitis in Mozambique, 2014: Implications for vaccination against meningococcal meningitis. [PDF]
PLoS One, 2018 Introduction In sub Saharan Africa, the epidemiology, including the distribution of serogroups of strains of N. meningitidis is poorly investigated in countries outside “the meningitis belt”.
Munguambe AM +7 more
europepmc +2 more sources
Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017. [PDF]
J Infect Dis, 2019 Background In 2010–2017, meningococcal serogroup A conjugate vaccine (MACV) was introduced in 21 African meningitis belt countries. Neisseria meningitidis A epidemics have been eliminated here; however, non-A serogroup epidemics continue.
Fernandez K +13 more
europepmc +2 more sources
Meningococcal Meningitis Surveillance in the African Meningitis Belt, 2004-2013. [PDF]
Clinical Infectious Diseases, 2015 BACKGROUND: An enhanced meningitis surveillance network was established across the meningitis belt of sub-Saharan Africa in 2003 to rapidly collect, disseminate, and use district weekly data on meningitis incidence.
Bergeron-Caron, Cassi +7 more
core +2 more sources
Awareness of Meningococcal disease among travelers from the United Kingdom to the meningitis belt in Africa [PDF]
American Journal of Tropical Medicine and Hygiene, 2018 Meningococcal disease causes considerable morbidity and has a high case-fatality rate. In the United Kingdom, the meningococcal quadrivalent vaccine is recommended for travelers visiting the meningitis belt of Africa. We analyzed 302 responses to a cross-
Goodman, Anna L. +3 more
core +2 more sources
The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine. [PDF]
Journal of Infectious Diseases, 2015 BACKGROUND: Study of meningococcal carriage is essential to understanding the epidemiology of Neisseria meningitidis infection. METHODS: Twenty cross-sectional carriage surveys were conducted in 7 countries in the African meningitis belt; 5 surveys were ...
MenAfriCar consortium
core +4 more sources
Meningitis and Meningococcal Septicaemia
Journal of the Royal College of Physicians of London, 1998 Pollard, A.J., Faust, S.N., Levin, M.
openaire +5 more sources